In addition to being diagnosed more frequently in older patients, pulmonary arterial hypertension (PAH) is more frequently diagnosed in patients with cardio-pulmonary comorbidities, which poses ...

In a widely expected decision, the Food and Drug Administration approved Merck’s Winrevair for injection, making it the first activin signaling inhibitor therapy for pulmonary arterial hypertension ...

Early initiation of macitentan and tadalafil therapy in PAH patients results in similar survival and hospitalization rates, regardless of diagnosis timing. Newly diagnosed PAH patients often present ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted orphan drug designation to ZMA001 as a treatment for patients with pulmonary arterial ...

Insmed Incorporated (INSM) is in a good position as a pharmaceutical company. It has already received regulatory approval in several territories for its drug known as ARIKAYCE which has been approved ...

On March 26th, the US FDA granted approval for Merck’s WINREVAIR™ (sotatercept-csrk), marking a significant milestone in pulmonary arterial hypertension (PAH) treatment. PAH, characterized by elevated ...

To assess how a patient with pulmonary arterial hypertension (PAH) is faring on therapy, look at the right heart, said Anjali Vaidya, MD, in a presentation at the Annual Meeting of the American ...

Please provide your email address to receive an email when new articles are posted on . Researchers used data from the GRIPHON study and open-label extension study. The median selexipag dose was 1,000 ...

A new phase 3 study comparing mono and duo therapies may yield greater guidance and treatment options for children with pulmonary arterial hypertension (PAH). PAH is a rare condition in children, but ...

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries that go from your heart to your lungs. It happens when these arteries become narrow or blocked, making it harder ...

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries in your lungs. It happens when these arteries become narrow or blocked, making it harder for blood to flow ...

An important part of managing pulmonary arterial hypertension is working with a specialist who understands this rare and ...